US Pharma MarketingThe post Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook appeared first on Medical Device Network.
Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook
Zimmer released its Q2 financials ahead of market open, prompting its shares on the New York Stock Exchange to rise by over 5% at market open on 5 August. The post Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook appeared first on Medical Device Network .
Zimmer released its Q2 financials ahead of market open, prompting its shares on the New York Stock Exchange to rise by over 5% at market open on 5 August.
Source: Medical Device Network